Vivos Inc (RDGL)

[DPep]

I agree, possibilities are there in many forms.
Vivos was requested to be more specific on the dossimetry calculations and maybe this is still part of that? I can imagine that the results would be used since the max tolerable dose levels of these trials is so much higher than standard Y-90 max dosing - almost double I believe.

Higher pinpoint tolerable doses = fewer treatment procedures = lower procedure, lower hospital, lower doctor costs. My wife has made an excellent point that why wouldn't big pharma buy them out and squelch the treatment so they can continue to make more money and bill more.

Wish I had a good answer for her. I just hope Doc stays committed. I would think insurance companies would love this as an alternative so they can reduce side effect law suits and generally save money for treatments.

I FEEL this will start its run by the end of this month to .2, then will get to .41 with approval.
It will shoot to $1.20 with national news coverage.